and premature atherosclerosisand thromboembolism (1, 2) . A moderate elevation of plasma homocysteine concentration is now fully recognized as an independent risk factor for cardiovascular disease (3, 4) . However, the precise mechanisms responsible for the association between hyperhomocysteinemia and increased risk of atherosclerosis and arterial and venous thrombosis are largely unknown.
The pioneer work of Harker and colleagues (5) had earlier suggested that endothelium injury and platelet hyperactivity were involved in the initiation of vascular disorders induced by experimental hyperhomocysteinemia.
The endothelial cytotoxicity of homocysteine has since been confirmed in vitro (6). Studies with cultured endothelial cells further suggested that homocysteine may impair the antithrombotic properties of the vessel wall by increasing the vascular procoagulant activity and platelet activation (7-9). (25) (26) (27) . As a consequence (see Fig. 1 ),requirements for Met and choline, the main exogenous sources of methyl groups, would be increased to maintain intracellular SAM concentrations (24, 28). Conversely, an acute Met load or an enrichment in dietary Met or animal protein increases tissue concentrations of SAM in rats (27, 29) . Consequently, the methionine excess reduces mobilization of the intracellular folate pool toward the regeneration of Met through a modulation of the N5"#{176}-methylene-tetrahydrofolate reductase (24, 28, 29 The absence of endotoxin in the incubation medium was confirmed using a chromogenic substrate (Biowhittaker). Nonadherent cells were removed by three washes with PBS and adherent cells (>98% macrophages) were further incubated for 3 h with or without 10 l.lg/ml lipopolysaccharide (LPS) from Escherichia coli 055:B5 (Difco). Finally; cells were disrupted by three freezing-thawing cycles. The capacity of macrophage homogenates to shorten the spontaneous recalcification time of a rat plasma was tested by a one stage coagulation assay performed using a KC1O coagulometer (Amelung). This macrophage-derived procoagulant activity corresponds to TF activity (22).
Platelet aggregation and thromboxane analyses
Platelets were prepared from blood drawn from rats fasted overnight into syringes containing 1 volume of anticoagulant (38 mmol/l citric acid; 75 mmol/l, sodium citrate; 136 mmol/ I glucose) for 3 volumes of blood. Aggregation experiments were performed as previously described (30). Briefly, washed platelets were adjusted to a count of 0.2 X 10' /ml in a Ca2-free Tyrode's buffer (pH 7.4), and 0.25 ml of the platelet suspension was dispensed in cuvettes and placed in a laser rheoaggregometer (Servibio, France Total plasma homocysteine (Hcys), cysteine (Cys), cysteinylglycine (Cys-Gly), and glutathione (GSH) concentrations were determined by HPLC performed in isocratic conditions with a Beckman Gold System equipped with a reverse phase column (C18 ODS, 150X4.6 mm, Beckman) and a fluorescence detector, using N-acetylcysteine as the internal standard (35). 
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Analysis of plasma amino acids
The internal standard (homoarginine, 100 nmol) was added to plasma samples (500 tl). The (Fig. 3A) . However, (Fig. 3B) ; again, ANOVA indicated that folicacid supply influenced the Met load-mediated change in TF activity (P<z0.0001).
Platelet activity
In dose-response studiesof the injectedMet, we have investigatedthe aggregation of washed platelets after stimulation by differentconcentrations of several in- Fig. 4B ). We thus chose to perform the routine determination of the plateletaggregation response in normal and FD animals afterthe Met load (0.1 g/kg) using 0.04 lU/mI thrombin and 0.45 .tmoI/l for ADP. The results, summarized in Fig.5A , B, confirm our previous observations of a higher response of platelets from FD animals than from controls (22). In addition, we found that the Met load induced an increase in platelet aggregation (about twofold and 15% for thrombin ( Fig. 5A) and ADP (Fig. 5B) were significantly and positively correlated with plasma Hcys levels and on macrophage TF and plateletactivities (Thr, ADP, and TXB2). The plateletparameters were also highly dependent on plasma Hcys levels(P<0.0001). These are illustrated in Fig.7A -C. The significantrelationship between plasma TBARS and circulating Hcys levels is also presented in Fig. 7D .
DISCUSSION
In this study we have developed a model of transient hyperhomocysteinemia induced by an acute Met load in rats. We found that the Met loading potentiated platelet activity and macrophage TF activity through mechanisms likely dependent on hyperhomocysteinemia-mediated enhancement of lipidperoxidation. These in vivo experiments applied to folicacid-deficient animals further contribute to the understanding of the mechanisms leading to hyperhomocysteinemia and associated vascular disease. Several linesof evidence strongly suggest a causal relationship between increased levelsof Hcys and cardiovascular disease, including atherosclerosis, as well as arterialand venous thrombosis (3, 4) .Three main factors are involved in the regulation of circulating Hcys, the de novo synthesis of which only occurs from Met. First, the inborn error of Hcys catabolism, characterized by a deficiency in cystathionine -synthase that converts Hcys to cystathionine ( Fig.1 ; reaction 5), represents the classical form of hyperhomocysteinemia (37). Second, a functionally important and common mutation in the gene coding for the enzyme N5'1#{176}-methylene-tetrahydrofolate reductase, which is involved in the remethylation of Hcys to Met (Fig. 1,  reaction 10), has now largely been described (38). Last, folate deficiency is thought to be the most common cause of moderate hyperhomocysteinemia. It could be due to suboptimal folate intake, to increased physiological requirements, or to altered metabolism of iatrogenic origin (3, 22, 39) . All these situations can be easily and rapidly reversed by folic acid supplementation (11, 40) .
Our experimental setup isbased on the use of Met loading to test the capacity of the Hcys catabolic system. Met loading was originally used in humans to detect subjects heterozygous for cystathionine 3-synthase deficiency and vitamin B6-deficient subjects (11, 37 (27, 29, 43). To determine the true thrombogenicity of elevated circulating Hcys, we used this Met challenge in normal and folate-deficient animals. Since we wanted to study the effects of moderate hyperhomocysteinemia, a dose of 0.1 g/kg was used, based on the results of our dose-response studies.
As expected, we found that in rats fed an adequate amount of folic acid, i.p. injections of Met led to increased plasma total Hcys. Conversely, folate-deficient rats did not show any significant posdoad increase in Hcys. These observations suggest that the Met loadmediated hyperhomocysteinemia resulted from an overload of the Hcys catabolism whereas the hyperhomocysteinemia due to folate deficiency resulted from a decrease in the Hcys catabolism, which could then be compensated by increasing the Met supply. Hcys. This idea is further strengthened by two series of results: first, the lack of an increase in platelet aggregation and thromboxane synthesis beyond that caused by folate deficiency; and second, the strong correlations between circulating Hcys levels and the above parameters (see Table 3 and Fig. 7) .
In recent years, several mechanisms have been proposed to explain how an elevated circulating Hcys might promote atherothrombosis. Although adverse effects of Hcys on endothelial cell thromboresistance, on smooth muscle cellproliferation,and on low density lipoprotein oxidation have been reported (6, 9, 23, 44) might be explained by a change in the thiol redox status (increase in reduced to total thiol ratio, mainly for Hcys and Cys), as a consequence of protein saturationtogether with the antioxidant properties of reduced thiolsin high concentrations (19, 48) . However, abundant experimental evidence supports the concept that hyperhomocysteinemia-induced atherosclerosis is the resultof an excessive production of oxygenated reactive species (6, 8, 16) . In the present study, we showed that circulatingoxidation products such as conjugated dienes, lipoperoxides, and TBARS were significantly increased after the Met load. Furthermore, significant correlations were found between platelet parameters (Thr, ADP, TXB2) and TBARS; TBARS and dienes were correlated with plasma Hcys (Table 3 and Fig. 7C, D) . These data confirm and 
